Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial Rapid Communication

Purpose This analysis of the FIRST trial in patients with newly diagnosed multiple myeloma (MM) ineligible for stem-cell transplantation examined updated outcomes and impact of patient age. Patients and Methods Patients with untreated symptomatic MM were randomly assigned at a one-to-one-to-one ratio to lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous), Rd for 72 weeks (18 cycles; Rd18), or melphalan, prednisone, and thalidomide (MPT; 72 weeks), stratified by age (≤ 75 v> 75 years), disease stage (International Staging System stage I/II v III), and country. The primary end point was progression-free survival. Rd continuous and MPT were primary comparators. Results Between August 21, 2008, and March 7, 2011, 1,623 patients were enrolled (Rd continuous, n = 535; Rd18, n = 541; MPT, n = 547), including 567 (35%) age older than 75 years. Higher rates of advanced-stage disease and renal impairment were observed in patients older than 75 versus 75 years of age or younger. Rd continuous reduced the risk of progression or death compared with MPT by 31% (hazard ratio [HR], 0.69; 95% CI, 0.59 to 0.80; P
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: Chemotherapy, Biology & Immunology, Rapid Communications Source Type: research

Related Links:

.
Source: International Journal of Sexual Health - Category: Sexual Medicine Authors: Source Type: research
.
Source: American Journal of Sexuality Education - Category: Sexual Medicine Authors: Source Type: research
.
Source: Systems Biology in Reproductive Medicine - Category: Sexual Medicine Authors: Source Type: research
.
Source: Systems Biology in Reproductive Medicine - Category: Sexual Medicine Authors: Source Type: research
.
Source: British Journal of Neurosurgery - Category: Neurosurgery Authors: Source Type: research
.
Source: British Journal of Neurosurgery - Category: Neurosurgery Authors: Source Type: research
.
Source: British Journal of Neurosurgery - Category: Neurosurgery Authors: Source Type: research
.
Source: British Journal of Neurosurgery - Category: Neurosurgery Authors: Source Type: research
.
Source: British Journal of Neurosurgery - Category: Neurosurgery Authors: Source Type: research
.
Source: British Journal of Neurosurgery - Category: Neurosurgery Authors: Source Type: research
More News: Cancer & Oncology